Speakers
Christina Fawcett
Senior Director, Decentralized Clinical Trial Operations
PRA Health Sciences
Day Two
Thursday, September 9, 2021
10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
Isaac Rodriguez-Chavez
Senior Vice President of Scientific & Clinical Affairs
PRA Health Sciences
Day One
Wednesday, September 8, 2021
10:25 am | Morning Q&A and Panel Forum
9:50 am | Innovation & High Impact on Patients’ Health Journey: Integrating Decentralized Clinical Trials (DCTs) with Clinical Research as a Care Option (CRAACO)
8:45 am | Chair’s Opening Remarks
Steven R. Cummings
Executive Director, San Francisco Coordinating Center
California Pacific Medical Center Research Institute
Day One
Wednesday, September 8, 2021
4:40 pm | Chair’s Closing Remarks
2:30 pm | Afternoon Q&A Panel Forum
1:40 pm | Removing Complexity: The Art of Cutting Tethers to the Trial Site
Amir Lahav
Healthcare Intelligence and Digital Transformation Consultant
Mitsubishi Tanabe Pharma America
Day Two
Thursday, September 9, 2021
10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
9:50 am | Morning Q&A & Panel Forum
9:00 am | New Trends in Remote Digital Monitoring Technology for Decentralized Trials in Patients with Neurodegenerative Diseases
8:50 am | Chair’s Opening Remarks
Tracey Robertson
Head of Digital Trials - Global Biostatistics & Data Sciences
Boehringer Ingelheim
Day One
Wednesday, September 8, 2021
4:20 pm | Closing Q&A & Panel Forum
3:55 pm | Designing a Hybrid Trial to Support Patient Choice
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
Day Two
Thursday, September 9, 2021
3:45 pm | Chair’s Closing Remarks
10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
Rachel Chasse
Director of Innovation
Digital Medicine Society (DiMe)
Day One
Wednesday, September 8, 2021
10:25 am | Morning Q&A and Panel Forum
9:25 am | DiMe on DCTs: Your How-To Guide
Daniel R Karlin
MD MA Chief Medical Officer
MindMed
Day Two
Thursday, September 9, 2021
3:00 pm | Panel: Too Hybrid, or Not to Hybridize?
2:45 pm | Afternoon Q&A & Panel Forum
1:30 pm | DCTs as Agile Clinical Experiments to Develop Novel Methods
Arturo Loaiza-Bonilla
Enterprise Director of Research
Cancer Treatment Centers of America
Day One
Wednesday, September 8, 2021
4:20 pm | Closing Q&A & Panel Forum
3:30 pm | Best Strategies to Optimize Patient Enrolment & Health Care Provider Engagement in the Digital Era: A Case Study
Mary C. Birmingham
PharmD, Director, Clinical Scientist
Janssen Scientific Affairs LLC
Day One
Wednesday, September 8, 2021
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
10:25 am | Morning Q&A and Panel Forum
9:00 am | Execution of a Randomized Decentralized Clinical Trial - a J&J Case Study
Rebecca Jackson
Clinical R&D SME - Clinical Data IT, Clinical Trials, Clinical Supply Chain
Johnson & Johnson
Day Two
Thursday, September 9, 2021
9:50 am | Morning Q&A & Panel Forum
9:25 am | Exploring the IMI Trials@Home Initiative
Jim Ternyila
Senior Business Relationship Manager - Digital Therapeutics
AstraZeneca
Day Two
Thursday, September 9, 2021
11:30 am | Using Vendors: What to Ask Them and What to Look For?
Amy Bohn
Study Operations Specialist, DCT Clinical Development
Bayer
Day One
Wednesday, September 8, 2021
12:10 pm | Evaluating Clinical Trials for a Decentralized Approach
Day Two
Thursday, September 9, 2021
3:00 pm | Panel: Too Hybrid, or Not to Hybridize?
Erica Lawson
Director, Applied Innovation
Otsuka
Day Two
Thursday, September 9, 2021
10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs
Arthur Combs
MD President
FutureTech Strategies, Inc.
Day Two
Thursday, September 9, 2021
3:00 pm | Panel: Too Hybrid, or Not to Hybridize?
Craig Lipset
Co-Chair
Decentralized Trials & Research Alliance (DTRA)
Day Two
Thursday, September 9, 2021
2:45 pm | Afternoon Q&A & Panel Forum
1:55 pm | Collaboration to Accelerate the Global Adoption of Decentralized Trials
Jim Hacunda
R&D Digital Strategy Lead
Takeda
Day One
Wednesday, September 8, 2021
2:30 pm | Afternoon Q&A Panel Forum
2:05 pm | Using Systems Modelling to Compare & Contrast Centralized vs Decentralized Clinical Trials
Vera Rulon
Founder and President
Tir Health Advisors
Ruth Schneider
MD, Assistant Professor of Neurology
University of Rochester
Day Two
Thursday, September 9, 2021
2:45 pm | Afternoon Q&A & Panel Forum
2:20 pm | Lessons from Observational, Remote Research Studies in Neurodegenerative Diseases
Gunilla Andrew-Nielsen
Head of Department of Clinical Trials and Special Permissions
Medical Products Agency
Day One
Wednesday, September 8, 2021
4:20 pm | Closing Q&A & Panel Forum
2:40 pm | Case Studies from Running Patient Centric Clinical Trials Supported by Remote & Virtual Elements
Jen Horonjeff
Founder & CEO
Savvy Cooperative
Day One
Wednesday, September 8, 2021
4:20 pm | Closing Q&A & Panel Forum
3:05 pm | Some ‘Savvy’ Solutions to Providing Your Patients with Choice in a Decentralized Clinical Trial
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
Brandon Maggio
Director of Digital & Process Optimization
GSK
Day One
Wednesday, September 8, 2021
11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?
Shoibal Datta
Head, R&D Digital Strategy Group, Data Sciences Institute
Takeda
Day Two
Thursday, September 9, 2021